United States · Law · S
S. 650 (108th)
Pediatric Research Equity Act of 2003
Introduced
18 March 2003
Last action
3 December 2003 · President
Status
Became Public Law No: 108-155.
Sponsors
Sen. DeWine, Mike [R-OH], Sen. Clinton, Hillary Rodham [D-NY], Sen. Gregg, Judd [R-NH], Sen. Dodd, Christopher J. [D-CT], Sen. Kennedy, Edward M. [D-MA], Sen. Murray, Patty [D-WA], Sen. Frist, William H. [R-TN]
Subjects
Healthcare
Source updated
21 April 2025
Summary
Pediatric Research Equity Act of 2003 - Amends the Federal Food, Drug, and Cosmetic Act to require license applications for new drugs and biological products to assess such drug's or product's safety and effectiveness for relevant pediatric subpopulations, including dosage. Permits deferral of such assessments under specified circumstances. Permits full waiver of such assessments under certain conditions, including if: (1) studies are highly impractical or impossible; or (2) there is no meaningful therapeutic advantage or benefit in the pediatric population. Permits partial waivers at the request of an applicant for a specific pediatric subpopulation if any of the full waiver grounds apply to that subpopulation or reasonable attempts for a pediatric formulation for that subpopulation have failed. Requires labels to provide indication in cases in which a waiver has been granted due to evidence a product would be unsafe or ineffective in pediatric populations. Authorizes the Secretary of Health and Human Services to specify a date for submission of pediatric assessments if: (1) the drug or biological product would represent a meaningful therapeutic benefit for pediatric patients for one or more claimed indications and the absence of adequate labeling could pose significant risks to pediatric patients; or (2) it is used for a number of pediatric patients for the labeled indications and the absence of adequate labeling could pose significant risks to pediatric patients. Sets forth criteria for full waiver and partial waivers of such requirement. Requires labels to provide indication in cases in which a waiver has been granted due to evidence a product would be unsafe or ineffective in pediatric populations. Requires the Secretary to issue a written request for related pediatric studies under the Public Health Service Act or under this Act before requiring an assessment for a drug. Directs the Secretary, after determining that there is no agreement to such a written request, to certify whether the Secretary has sufficient funds to conduct the study under the Public Health Service Act, taking into account prioritization of drugs for which pediatric studies are needed. States that if a person fails to submit an assessment under this Act, or a request for approval of a pediatric formulation, the relevant drug or biological product may be considered misbranded and subject to enforcement action.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
18 March 2003
Introduced
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S3898-3900)
Source: IntroReferral
18 March 2003
Introduced
Sponsor introductory remarks on measure. (CR S3897-3898)
Source: IntroReferral
18 March 2003
Introduced
Introduced in Senate
Source: IntroReferral
19 March 2003
Reported
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment favorably.
Source: Committee
27 June 2003
Calendars
Placed on Senate Legislative Calendar under General Orders. Calendar No. 183.
Source: Calendars
27 June 2003
Reported
Committee on Health, Education, Labor, and Pensions. Reported by Senator Gregg with an amendment. With written report No. 108-84. Additional views filed.
Source: Committee
27 June 2003
Reported
Committee on Health, Education, Labor, and Pensions. Reported by Senator Gregg with an amendment. With written report No. 108-84. Additional views filed.
Source: Committee
23 July 2003
Reported
Measure laid before Senate by unanimous consent. (consideration: CR S9811-9819; text of measure as reported in Senate: CR S9811-9813)
Source: Floor
23 July 2003
Passed
Passed/agreed to in Senate: Passed Senate with amendments by Unanimous Consent.(text as passed Senate: CR S9816-9818)
Source: Floor
24 July 2003
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
24 July 2003
Floor
Received in the House.
Source: Floor
24 July 2003
Floor
Message on Senate action sent to the House.
Source: Floor
8 August 2003
Referred
Referred to the Subcommittee on Health.
Source: Committee
19 November 2003
Floor
DEBATE - The House proceeded with forty minutes of debate on S. 650.
Source: Floor
19 November 2003
Floor
Considered under suspension of the rules. (consideration: CR H11567-11572)
Source: Floor
19 November 2003
Passed
Motion to reconsider laid on the table Agreed to without objection.
Source: Floor
19 November 2003
Passed
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H11567-11569)
Source: Floor
19 November 2003
Passed
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H11567-11569)
Source: Floor
19 November 2003
Floor
Mr. Bilirakis moved to suspend the rules and pass the bill.
Source: Floor
21 November 2003
Floor
Presented to President.
Source: Floor
21 November 2003
President
Presented to President.
Source: President
3 December 2003
Became law
Became Public Law No: 108-155.
Source: President
3 December 2003
Became law
Signed by President.
Source: BecameLaw
3 December 2003
President
Signed by President.
Source: President
Votes
No vote records are attached yet.
Versions
- Enrolled Bill · — · Download file
- Public Law · 3 December 2003 · Download file
- Referred in House · 24 July 2003 · Download file
- Engrossed in Senate · 23 July 2003 · Download file
- Reported to Senate · 27 June 2003 · Download file
- Introduced in Senate · 18 March 2003 · Download file
Documents
15 official files
Enrolled Bill (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Enrolled Bill (text)
Enrolled Bill · EN
Enrolled Bill (PDF)
Enrolled Bill · EN
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Public Law (text)
Public Law · EN · 3 December 2003
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Public Law (PDF)
Public Law · EN · 3 December 2003
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Public Law
summary · EN · 3 December 2003
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Referred in House (text)
Referred in House · EN · 24 July 2003
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Referred in House (PDF)
Referred in House · EN · 24 July 2003
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Engrossed in Senate (text)
Engrossed in Senate · EN · 23 July 2003
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Engrossed in Senate (PDF)
Engrossed in Senate · EN · 23 July 2003
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Passed Senate amended
summary · EN · 23 July 2003
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Reported to Senate (text)
Reported to Senate · EN · 27 June 2003
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Reported to Senate (PDF)
Reported to Senate · EN · 27 June 2003
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in Senate (text)
Introduced in Senate · EN · 18 March 2003
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in Senate (PDF)
Introduced in Senate · EN · 18 March 2003
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in Senate
summary · EN · 18 March 2003
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Sen. DeWine, Mike [R-OH] · R · Sponsor
- Sen. Clinton, Hillary Rodham [D-NY] · D · Sponsor
- Sen. Gregg, Judd [R-NH] · R · Sponsor
- Sen. Dodd, Christopher J. [D-CT] · D · Sponsor
- Sen. Kennedy, Edward M. [D-MA] · D · Sponsor
- Sen. Murray, Patty [D-WA] · D · Cosponsor
- Sen. Frist, William H. [R-TN] · R · Cosponsor
- · hsif00 · Standing
- · sshr00 · Standing
Related records
Related across the Repo ecosystem
Direct relationships are identifier-backed. Topic context means shared TopicMembership — not a citation and not causation.
Direct relationships
- Legal framework · Pediatric Research Equity Act of 2003 · S. 650 (108th) · US
- Identifier matchPROJECTS_FROM
Same us record 108-s-650 projected from PoliticalRepo US row.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/108th-congress/senate-bill/650
- Open data entity: https://api.congress.gov/v3/bill/108/s/650
- us · 108-s-650 · source updated 21 April 2025